RecruitingNCT06322290

Epidemiological Study on Invasive Bacterial Diseases

Epidemiological Study on Invasive Bacterial Diseases (IBD)


Sponsor

Meyer Children's Hospital IRCCS

Enrollment

5,000 participants

Start Date

Dec 9, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae (hemophilus) are among the main bacteria responsible for invasive bacterial diseases (MBIs) that result in severe clinical pictures also characterized by a high frequency of serious complications. Surveillance of infections caused by these pathogens and their distribution by serotypes/serogroups is essential to guide public health interventions, assess epidemiologic trends, monitor any secondary cases, estimate the proportion of preventable cases, identify any vaccine failures, and evaluate the impact of vaccine strategies.The present study aims to study the epidemiology of invasive bacterial diseases, characterize the circulating strains also in order to plan treatment and prevention strategies.


Eligibility

Min Age: 1 DayMax Age: 70 Years

Inclusion Criteria1

  • Pediatric and adult patients diagnosed with pneumococcal, meningococcal, and hemophilus MBI

Exclusion Criteria1

  • Other type of bacterial infections.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTassessment of pathogens in blood specimens

Molecular diagnosis of Invasive bacterial diseases due to Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae


Locations(38)

Ospedale di Adria

Adria, Italy

Ospedali riuniti di Ancona

Ancona, Italy

Ospedale di Andria

Andria, Italy

Ospedale Giovanni XXIII

Bari, Italy

Policlinico S.Orsola-Malpighi IRCCS

Bologna, Italy

Fondazione poliambulanza Brescia

Brescia, Italy

Ospedale Giovanni XXIII

Brescia, Italy

Ospedale di Campobasso

Campobasso, Italy

Ospedale Camposampiero

Camposampiero, Italy

Ospedale di Esine asst Valcamonica

Esine, Italy

Ospedale di Feltre (AULSS 1 Dolomiti)

Feltre, Italy

Immunology Laboratory Meyer Children's Hospital IRCCS

Florence, Italy

Ospedale Morgagni

Forlì, Italy

AO Salvini di Garbagnate

Garbagnate, Italy

Azienda sanitaria universitaria Giuliano Isontina (ASU GI)

Gorizia, Italy

Ospedale di Macerata

Macerata, Italy

Ospedale di Magenta

Magenta, Italy

Azienda Ospedaliera Policlinico Universitario "G. Martino"

Messina, Italy

IRCCS San Raffaele

Milan, Italy

AORN Santobono

Naples, Italy

AOU Federico II di Napoli

Naples, Italy

Ospedale di Novara

Novara, Italy

Fondazione I.R.C.C.S. Policlinico San Matteo

Pavia, Italy

Ospedale spirito santo di Pescara

Pescara, Italy

Azienda sanitaria Friuli occidentale

Pordenone, Italy

Ospedale degli infermi

Rimini, Italy

Ospedale Pediatrico Bambin Gesù IRCCS

Roma, Italy

Ospedale Sandro Pertini

Roma, Italy

Ospedale San Leonardo di Salerno

Salerno, Italy

Ospedale di Saronno

Saronno, Italy

AOU Sassari

Sassari, Italy

Ospedale di Scorrano

Scorrano, Italy

ASP Trapani

Trapani, Italy

IRCCS Materno Infantile Burlo Garofolo

Trieste, Italy

Azienda sanitaria universitaria Friuli Centrale (ASU FC)

Udine, Italy

Azienda ospedaliera universitaria integrata Verona

Verona, Italy

Ospedale civile di Vibo Valentia

Vibo Valentia, Italy

Ospedale Maggiore Carlo Alberto Pizzardi

Bologna, Ì, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06322290


Related Trials